Document Detail


Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
MedLine Citation:
PMID:  25472874     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
High von Willebrand factor (VWF) plasma levels are associated with an increased risk of coronary artery disease. It has been suggested that the increase of VWF levels is partly due to endothelial dysfunction and atherosclerosis. Our aim was to investigate the association between coronary plaque burden, the presence of high-risk coronary lesions as measured by intravascular ultrasound virtual histology (IVUS-VH) and VWF levels. In addition, we studied the association between VWF levels and one-year cardiovascular outcome. Between 2008 and 2011, IVUS-VH imaging of a non-culprit coronary artery was performed in 581 patients undergoing coronary angiography for acute coronary syndrome (ACS) (n= 318) or stable angina pectoris (SAP) (n= 263). Arterial blood was sampled prior to the coronary angiography. VWF antigen (VWF:Ag) levels were measured using ELISA (n= 577). Patients with ACS had significantly higher VWF:Ag levels than SAP patients (median 1.73 IU/ml [IQR 1.27-2.31] vs 1.26 IU/ml [0.93-1.63], p< 0.001). High coronary plaque burden was associated with higher VWF:Ag levels (β= 0.12, p=0.027) in SAP patients, but not in ACS patients. In ACS patients, VWF:Ag levels were associated with 1-year MACE (HR 4.14 per SD increase of lnVWF:Ag, 95 % CI 1.47-11.6), whereas in SAP patients VWF:Ag levels predicted 1-year all-cause death and hospitalisation for ACS (HR 7.07 95 % CI 1.40-35.6). In conclusion, coronary plaque burden was associated with VWF:Ag levels in SAP patients undergoing coronary angiography. In ACS and SAP patients, high VWF levels are predictive of adverse cardiovascular outcome and death during one-year follow-up.
Authors:
M A H Sonneveld; J M Cheng; R M Oemrawsingh; M P M de Maat; I Kardys; H M Garcia-Garcia; R-J van Geuns; E Regar; P W Serruys; E Boersma; K M Akkerhuis; F W G Leebeek
Related Documents :
15135254 - The -344t>c promoter variant of the gene for aldosterone synthase (cyp11b2) is not asso...
20554334 - Coronary artery disease, coronary revascularization, and outcomes in chronic advanced s...
25276614 - Site-specific intravascular ultrasound analysis of remodelling index and calcified necr...
21126614 - Comparison of prognostic value of echographic [corrected] risk score with the thromboly...
11348034 - Molecular mechanism of cardiac hypertrophy and development.
11885144 - Affairs of the heart: patients' personal constructions of a cardiac event and their eff...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-04
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  113     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-4     Completed Date:  -     Revised Date:  2014-12-5    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Independent overexpression of the subunits of translation elongation factor complex eEF1H in human l...
Next Document:  Neonatal circumcision in severe haemophilia: a survey of paediatric haematologists at United States ...